Perturbing the Normal Level of SIDT1 Suppresses the Naked ASO Effect
Although antisense oligonucleotide (ASO) therapeutics can be taken up by living cells without carrier molecules, a large part of incorporated ASOs are trapped in the endosomes and do not exert therapeutic effects. To improve their therapeutic effects, it would be important to elucidate the mechanism...
Saved in:
| Main Authors: | Masayuki Takahashi, Mineaki Seki, Masayuki Nashimoto, Tomohiro Kabuta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Nucleic Acids |
| Online Access: | http://dx.doi.org/10.1155/2021/2458470 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of Sidt2 on the Inflammatory Pathway in Mouse Mesangial Cells
by: Hui Sun, et al.
Published: (2020-01-01) -
Effect of sidt2 Gene on Cell Insulin Resistance and Its Molecular Mechanism
by: Qian-Ying Xiong, et al.
Published: (2020-01-01) -
Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides
by: Kohshi Kusumoto, et al.
Published: (2025-01-01) -
Dual activity of PNGM-1 pinpoints the evolutionary origin of subclass B3 metallo-β-lactamases: a molecular and evolutionary study
by: Jung Hun Lee, et al.
Published: (2019-01-01) -
Comprehensive review of adverse reactions and toxicology in ASO-based therapies for Duchenne Muscular Dystrophy: From FDA-approved drugs to peptide-conjugated ASO
by: Umme Sabrina Haque, et al.
Published: (2024-01-01)